Eli Lilly News

Robert Ravenell spent every morning for two weeks outside the limestone quarry he said put cracks in the bricks of his house.

Amylin Pharmaceuticals got a triple dose of good news over the weekend. Individually, each update might not have amounted to much, but together they were good for a 10% pop in the company's shares yesterday.

South Carolina, trying to curb abuse of narcotics and save money, is requiring Medicaid patients suspected of doctor-hopping for drugs to choose one pharmacy for all of their prescriptions.

Indianapolis-based Eli Lilly plans to layoff 191 salespeople throughout the US by the end of the year.

In a speech today to the City Club of San Diego, John C. Lechleiter, Ph.D., chairman and chief executive officer of Eli Lilly and Company , said that the engine of biopharmaceutical innovation is "broken." He offered a vision for biopharmaceutical companies to "reinvent innovation" to make the most of today's wealth of scientific knowledge to ...

ICON plc, , a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has signed an extension to its strategic agreement with Eli Lilly and Company to manage the companya s clinical data management outside the US.

Pharmaceutical giant Eli Lilly opened a new state-of-the-art biotechnology center in San Diego, part of an ongoing effort by the drugmaker to transform itself into a biotech titan.

Eli Lilly and Co. has opened its new Biotechnology Center in San Diego, as part of its strategy to develop more biopharmaceuticals.

Amylin Pharmaceuticals, Inc., and Eli Lilly and Company today announced that the U.S. Food and Drug Administration has approved an expanded indication for BYETTAA injection.

Eli Lilly and Company and the government entered into an agreement whereby Eli Lilly agrees to plead guilty to the introduction into interstate commerce of quantities of its drug, Zyprexa, that were misbranded in violation of 21 U.S.C. 331 , 333 and 352 .

Pharmaceutical giant Eli Lilly and Co. on Thursday opened a biotechnology center in La Jolla that will house nearly 200 of its scientists.

Lung cancer is the world's most common cancer, and an estimated 219,440 Americans are expected to be diagnosed this year.

Not unlike its products that turn ugly mixtures into purer products, Waters turned an ugly top line into an acceptable earnings growth in the third quarter.

Among the earnings stories for Wednesday, Oct. 21, from AP Financial News: WASHINGTON - Northrop Grumman Corp.

GE Healthcare plans to expand a cancer drug research partnership with Eli Lilly & Co., making a 2-year-old partnership official in the process.

Eli Lilly CEO John Lechleiter thinks a reorganization announced last month will help the company withstand upcoming patent losses of some of its top-selling drugs.

Eli Lilly & Co. lost a bid for a hearing before Canadaa s highest court on whether its patent for the Evista osteoporosis treatment is valid as the company tried to block Apotex Inc.

Attorney General Henry McMaster said today South Carolina has reached a $45 million settlement agreement with pharmaceutical giant Eli Lilly over the company's marketing of the anti-psychotic drug Zyprexa.

Name: John C. Lechleiter Occupation: chairman, president and CEO of Eli Lilly and Co.

Eli Lilly and Co.'s chairman and CEO, Leichleiter brings some of his childhood lessons to bear in leading the major drug company, which is based in Indianapolis.